Clinical Trial Update: Effects of Empagliflozin on Clinical Outcomes in Patients With Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effects of empagliflozin on outcomes in patients with acute decompensated heart failure; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure
• Heart Failure

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University Medical Center Groningen | Conditions: Heart Failure Acute, Heart Failure，Congestive | Phase 2 | Status: COMPLETED | Results posted: 2020-02-19